1. bookTom 49 (2015): Zeszyt 2 (June 2015)
Informacje o czasopiśmie
License
Format
Czasopismo
eISSN
1581-3207
Pierwsze wydanie
30 Apr 2007
Częstotliwość wydawania
4 razy w roku
Języki
Angielski
Open Access

Primary central nervous system lymphoma: is absence of intratumoral hemorrhage a characteristic finding on MRI?

Data publikacji: 25 Mar 2015
Tom & Zeszyt: Tom 49 (2015) - Zeszyt 2 (June 2015)
Zakres stron: 128 - 134
Otrzymano: 12 Aug 2014
Przyjęty: 06 Jan 2015
Informacje o czasopiśmie
License
Format
Czasopismo
eISSN
1581-3207
Pierwsze wydanie
30 Apr 2007
Częstotliwość wydawania
4 razy w roku
Języki
Angielski

1. Haldorsen IS, Kråkenes J, Krossnes BK, Mella O, Espeland A. CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003. AJNR Am J Neuroradiol 2009; 30: 744-51.10.3174/ajnr.A1447Search in Google Scholar

2. Bataille B, Delwail V, Menet E, Vandermarcq P, Ingrand P, Wager M, et al. Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 2000; 92: 261-6.10.3171/jns.2000.92.2.0261Search in Google Scholar

3. Schlegel U, Schmidt-Wolf IG, Deckert M. Primary CNS lymphoma: clinical presentation, pathological classification, molecular pathogenesis and treatment. J Neurol Sci 2000; 181: 1-12.10.1016/S0022-510X(00)00385-3Search in Google Scholar

4. Olson JE, Janney CA, Rao RD, Cerhan JR, Kurtin PJ, Schiff D, et al. The continuing increase in the incidence of primary central nervous system non- Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer 2002; 95: 1504-10.10.1002/cncr.10851Search in Google Scholar

5. Geppert M, Ostertag CB, Seitz G, Kiessling M. Glucocorticoid therapy obscures the diagnosis of cerebral lymphoma. Acta Neuropathol 1990; 80: 629-34.10.1007/BF00307631Search in Google Scholar

6. Zhang D, Hu L-B, Henning TD, Ravarani EM, Zou LG, Feng XY, et al. MRI findings of primary CNS lymphoma in 26 immunocompetent patients. Korean J Radiol 2010; 11: 269-77.10.3348/kjr.2010.11.3.269Search in Google Scholar

7. Bühring U, Herrlinger U, Krings T, Thiex R, Weller M, Küker W. MRI features of primary central nervous system lymphomas at presentation. Neurology 2001; 57: 393-6.10.1212/WNL.57.3.393Search in Google Scholar

8. Jenkins CN, Colquhoun IR. Characterization of primary intracranial lymphoma by computed tomography: an analysis of 36 cases and a review of the literature with particular reference to calcification haemorrhage and cyst formation. Clin Radiol 1998; 53: 428-34.10.1016/S0009-9260(98)80271-7Search in Google Scholar

9. Ueda F, Takashima T, Suzuki M, Kadoya M, Yamashita J, Kida T. MR imaging of primary intracranial malignant lymphoma. Radiat Med 1995; 13: 51-7.Search in Google Scholar

10. Coulon A, Lafitte F, Hoang-Xuan K, Martin-Duverneuil N, Mokhtari K, Blustajn J, et al. Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients. Eur Radiol 2002; 12: 329-40.10.1007/s00330010103711870430Search in Google Scholar

11. Haldorsen IS, Espeland A, Larsson E-M. Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. AJNR Am J Neuroradiol 2011; 32: 984-92.10.3174/ajnr.A2171801315720616176Search in Google Scholar

12. Yamashita K, Yoshiura T, Hiwatashi A, Togao O, Yoshimoto K, Suzuki SO, et al. Differentiating primary CNS lymphoma from glioblastoma multiforme: assessment using arterial spin labeling, diffusion-weighted imaging, and ą⁸F-fluorodeoxyglucose positron emission tomography. Neuroradiology 2013; 55: 135-43.10.1007/s00234-012-1089-622961074Search in Google Scholar

13. Kim HS, Jahng GH, Ryu CW, Kim SY. Added value and diagnostic performance of intratumoral susceptibility signals in the differential diagnosis of solitary enhancing brain lesions: preliminary study. AJNR Am J Neuroradiol 2009; 30: 1574-9.10.3174/ajnr.A1635705162619461062Search in Google Scholar

14. Radbruch A, Wiestler B, Kramp L, Lutz K, Bäumer P, Weiler M, et al. Differentiation of glioblastoma and primary CNS lymphomas using susceptibility weighted imaging. Eur J Radiol 2013; 82: 552-6.10.1016/j.ejrad.2012.11.00223238364Search in Google Scholar

15. Peters S, Knöß N, Wodarg F, Cnyrim C, Jansen O. Glioblastomas vs. lymphomas: more diagnostic certainty by using susceptibility-weighted imaging (SWI). Rofo 2012; 184: 713-8.10.1055/s-0032-131286222618484Search in Google Scholar

16. Rubenstein J, Fischbein N, Aldape K, Burton E, Shuman M. Hemorrhage and VEGF expression in a case of primary CNS lymphoma. J Neurooncol 2002; 58: 53-6.10.1023/A:1015887312455Search in Google Scholar

17. Kim IY, Jung S, Jung TY, Kang SS, Choi C. Primary central nervous system lymphoma presenting as an acute massive intracerebral hemorrhage: case report with immunohistochemical study. Surg Neurol 2008; 70: 308-11.10.1016/j.surneu.2007.04.00918207523Search in Google Scholar

18. Kimura N, Ishibashi M, Masuda T, Ito M, Takahashi Y, Kumamoto T. Primary central nervous system lymphoma with cortical laminar hemorrhage. J Neurol Sci 2009; 287: 281-4.10.1016/j.jns.2009.07.02219699492Search in Google Scholar

19. Kickingereder P, Wiestler B, Sahm F, Heiland S, Roethke M, Schlemmer HP, et al. Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility- weighted MR imaging. Radiology 2014; 272: 843-50.10.1148/radiol.1413274024814181Search in Google Scholar

20. Higano S, Yun X, Kumabe T, Watanabe M, Mugikura S, Umetsu A, et al. Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology 2006; 241: 839-46.10.1148/radiol.241305127617032910Search in Google Scholar

21. Ding Y, Xing Z, Liu B, Lin X, Cao D. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastases using susceptibility-weighted imaging. Brain and Behavior 2014; 4: 841-9.10.1002/brb3.288421211125365807Search in Google Scholar

22. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-4510.2307/2531595Search in Google Scholar

23. Kondziolka D, Bernstein M, Resch L, Tator CH, Fleming JF, Vanderlinden RG, et al. Significance of hemorrhage into brain tumors: clinicopathological study. J Neurosurg 1987; 67: 852- 7.10.3171/jns.1987.67.6.08523316531Search in Google Scholar

24. Bagley LJ, Grossman RI, Judy KD, Curtis M, Loevner LA, Polansky M, et al. Gliomas: correlation of magnetic susceptibility artifact with histologic grade. Radiology 1997; 202: 511-6.10.1148/radiology.202.2.90150829015082Search in Google Scholar

25. Li C, Ai B, Li Y, Qi H, Wu L. Susceptibility-weighted imaging in grading brain astrocytomas. Eur J Radiol 2010; 75: e81-5.10.1016/j.ejrad.2009.08.00319726149Search in Google Scholar

26. Furtner J, Schöpf V, Preusser M, Asenbaum U, Woitek R, Wöhrer A, et al. Non-invasive assessment of intratumoral vascularity using arterial spin labeling: A comparison to susceptibility-weighted imaging for the differentiation of primary cerebral lymphoma and glioblastoma. Eur J Radiol 2014; 83: 806-10.10.1016/j.ejrad.2014.01.01724613549Search in Google Scholar

27. Deckert M, Paulus W. Malignant lymphoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO classification of tumours of the central nervous system. 4th ed. Lyon, France: International Agency for Research on Cancer, 2007. p. 188-92.Search in Google Scholar

28. Haacke EM, Mittal S, Wu Z, Neelavalli J, Cheng YC. Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol 2009; 30: 19-30.10.3174/ajnr.A1400380539119039041Search in Google Scholar

29. Mittal S, Wu Z, Neelavalli J, Haacke EM. Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol 2009; 30: 232-52.10.3174/ajnr.A1461380537319131406Search in Google Scholar

30. Nandigam RN, Viswanathan A, Delgado P, Skehan ME, Smith EE, Rosand J, et al. MR imaging detection of cerebral microbleeds: effect of susceptibility- weighted imaging, section thickness, and field strength. AJNR Am J Neuroradiol 2009; 30: 338-43.10.3174/ajnr.A1355276029819001544Search in Google Scholar

31. Wiggins GC, Triantafyllou C, Potthast A, Reykowski A, Nittka M, Wald LL. 32-channel 3 Tesla receive-only phased-array head coil with soccer-ball element geometry. Magn Reson Med 2006; 56: 216-23.10.1002/mrm.2092516767762Search in Google Scholar

32. Constable RT, Henkelman RM. Contrast, resolution, and detectability in MR imaging. J Comput Assist Tomogr 1991; 15: 297-303.10.1097/00004728-199103000-000212002111Search in Google Scholar

33. Kale SC, Chen XJ, Henkelman RM. Trading off SNR and resolution in MR images. NMR Biomed 2009; 22: 488-94.10.1002/nbm.135919123210Search in Google Scholar

34. Ahn SJ, Shin HJ, Chang JH, Lee SK. Differentiation between primary cerebral lymphoma and glioblastoma using the apparent diffusion coefficient: comparison of three different ROI Methods. PLoS One 2014; 9: e112948.10.1371/journal.pone.0112948423109925393543Search in Google Scholar

35. Matsushima N, Maeda M, Umino M, Suzawa N, Yamada T, Takeda K. Relation between FDG uptake and apparent diffusion coefficients in glioma and malignant lymphoma. Ann Nucl Med 2012; 26: 262-71.10.1007/s12149-012-0570-y22311413Search in Google Scholar

36. Weller M. Glucocorticoid treatment of primary CNS lymphoma. J Neurooncol 1999; 43: 237-9.10.1023/A:1006254518848Search in Google Scholar

37. Kim EY, Kim SS. Magnetic resonance findings of primary central nervous system T-cell lymphoma in immunocompetent patients. Acta Radiol 2005; 46: 187-92.10.1080/0284185051002271415902895Search in Google Scholar

38. Lee HY, Kim HS, Park JW, Baek HJ, Kim SJ, Choi CG. Atypical imaging features of epstein-barr virus-positive primary central nervous system lymphomas in patients without AIDS. AJNR Am J Neuroradiol 2013; 34: 1562-7.10.3174/ajnr.A3429805146523413244Search in Google Scholar

Polecane artykuły z Trend MD

Zaplanuj zdalną konferencję ze Sciendo